About
Company/Facility
Executive Team and Board of Directors
Join Our Team
Contact Us
Supplier Terms & Conditions
Materials
Silicon Nitride
Industrial (STX-100)
Biomedical (FleX-SN)
BoroShock
DuraShock
Applications
Biomedical
Antipathogenic
Armor
Industrial Applications
SINTX-MD
Resources
Press/News
Events
Presentations
Publications
Case Studies
Research/Literature
Patents
Blog
References
OEM Solutions
Ceramic 3D Printing
Investors
Search
Contact Us
Close
About
Company/Facility
Executive Team and Board of Directors
Join Our Team
Contact Us
Supplier Terms & Conditions
Materials
Silicon Nitride
Industrial (STX-100)
Biomedical (FleX-SN)
BoroShock
DuraShock
Applications
Biomedical
Antipathogenic
Armor
Industrial Applications
SINTX-MD
Resources
Press/News
Events
Presentations
Publications
Case Studies
Research/Literature
Patents
Blog
References
OEM Solutions
Ceramic 3D Printing
Investors
Search
Contact Us
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
3
4
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFN14A
DEFR14A
DRS
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PREC14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2008
2007
2004
2003
Date
Form
Description
PDF
XBRL
Pages
10/11/23
8-K
Current report filing
Documents
EX-99.1
3
08/08/23
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-31.2
EX-32
19
05/15/23
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-31.2
EX-32
18
03/29/23
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-4.18
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32
62
02/16/23
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
02/14/23
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
EX-99.1
9
02/09/23
8-K
Current report filing
Documents
EX-4.5
EX-10.1
EX-99.1
27
02/09/23
424B4
Prospectus filed pursuant to Rule 424(b)(4)
88
02/08/23
POS EX
Post-effective amendment filed solely to add exhibits to a registration statement
Documents
EX-5.1
3
02/07/23
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
Previous
1…
2
3
4
5
6
7
8
9
10
11
…57
Next
Email Alerts
Contacts
RSS News Feed